NEUROGENE INC (NGNE) Stock Income Statement
NASDAQ:NGNE - Nasdaq - US64135M1053 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 925.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 83.43M | 55.58M | 59.10M | 60.70M | 41.55M | |||
| Research and Development | 60.82M | 44.39M | 41.13M | 39.16M | 24.34M | |||
| Selling, General, and Administrative Expenses | 22.61M | 11.19M | 17.97M | 21.54M | 17.21M | |||
| Operating Income | -82.50M | -55.58M | -59.10M | -60.70M | -41.55M | |||
| Interest Income/Expense | 8.46M | 2.94M | 1.58M | 18.00K | 495.00K | |||
| Other Income/Expense | -994.00K | -28.00K | -42.00K | -12.00K | -44.00K | |||
| Non Recurring Items | -100.00K | 16.36M | N/A | 0.00 | 7.83M | |||
| Income Before Taxes | -75.14M | -36.32M | -57.56M | -60.69M | -33.28M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -75.14M | -36.32M | -57.56M | -60.69M | -33.28M | |||
| EBITDA | -79.31M | -52.32M | -57.54M | -59.39M | -40.77M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.28 | -2.83 | -104.26 | -110.34 | -64.24 | |||
| Non GAAP EPS | -4.27 | N/A | -8.80 | -2.20 | -0.81 | |||
| Statistics | ||||||||
| Profit Margin | -8123.68% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | -8919.46% | N/A | N/A | N/A | N/A | |||
All data in USD